Best of AC2017 Session - Investigational Drugs - On-Demand

    • List Price: $35.00
    • Member Price: $25.00

Session for the HOPA AC2017

Investigational Drugs - Genomic-Enabled Brain Tumor Therapeutics

This session will delineate the role of an oncology clinical pharmacist on a Molecular Tumor Board. The elements and sequence of events that lead to a treatment recommendation will be illustrated, followed by a presentation of the finding and results from the first precision medicine study in patients with recurrent GBM. New actionable targets will be identified that are modulated by our currently available pharmacopeia.


Content Area: Research; Patient Management & Therapeutics

"Basket Trials": An Exciting New Era in Cancer Treatment

This session will discuss basket trials as a new clinical trial design in cancer treatment. Traditional clinical trials focus on a particular cancer type, but basket studies concentrate on a specific mutation found in the tumor, regardless of where the cancer originated. Basket studies provide an important opportunity to test therapies for rare cancers, including pediatric cancers. This session will summarize two ongoing basket trials in pediatric and adult cancers, briefly explain the scientific rationale of these trials, and discuss the potential roles of clinical pharmacists in a basket trial clinic.


Content Area: Research; Patient Management & Therapeutics


Product Details:

Genomic-Enabled Brain Tumor Therapeutics

Speaker: John Kuhn, PharmD FCCP

Learning Objectives:

1.      Describe the components of a therapeutic recommendation based on molecular defined actionable targets in glioblastoma multiforme (GBM).

2.      Iden...

Show More
There are not any reviews for this product.
Contains 0 items
Subtotal: $0.00